Investors
Gimv

Gimv is a venture capital fund based in Antwerp, investing in companies at early growth to established phases, with funding ranging from 5 million to 75 million euros. The firm focuses on sectors like biotech, health tech, pharma, and deep tech. Notable investments include SynOx Therapeutics and FIRE1. Gimv primarily targets businesses in the Benelux region, France, and Germany, aiding their expansion and innovation.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Recent Investments